89 related articles for article (PubMed ID: 8880212)
21. Cloning and expression of the human tumor-specific antibody GM4.
Nasoff MS; Gu M; Galindo J; He XM; Mukerjee S; McKnight M; Glassy MC
Hybridoma; 1997 Oct; 16(5):427-39. PubMed ID: 9388026
[TBL] [Abstract][Full Text] [Related]
22. Mouse monoclonal antibody to a melanoma-carcinoma-associated antigen synthesized by a human melanoma cell line propagated in serum-free medium.
Chee DO; Yonemoto RH; Leong SP; Richards GF; Smith VR; Klotz JL; Goto RM; Gascon RL; Drushella MM
Cancer Res; 1982 Aug; 42(8):3142-7. PubMed ID: 7046918
[TBL] [Abstract][Full Text] [Related]
23. A strategy for the production of human monoclonal antibodies reactive with lung tumor cell lines.
Cole SP; Campling BG; Louwman IH; Kozbor D; Roder JC
Cancer Res; 1984 Jul; 44(7):2750-3. PubMed ID: 6327024
[TBL] [Abstract][Full Text] [Related]
24. Lymphocyte surface marker expression on hybridomas secreting human monoclonal antibodies.
Seifert M; Jahn S; Schwab J; Döcke W; Volk HD; von Baehr R
Hum Antibodies Hybridomas; 1992 Apr; 3(2):86-92. PubMed ID: 1633269
[TBL] [Abstract][Full Text] [Related]
25. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
Woodhouse CS; Morgan AC
Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
[TBL] [Abstract][Full Text] [Related]
26. Human-human hybridomas secreting antibodies specific to human lung carcinoma.
Murakami H; Hashizume S; Ohashi H; Shinohara K; Yasumoto K; Nomoto K; Omura H
In Vitro Cell Dev Biol; 1985 Oct; 21(10):593-6. PubMed ID: 3902783
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody against A1 Lewis d antigen produced by the hybridoma immunized with a pulmonary carcinoma.
Iwaki Y; Kasai MK; Terasaki PI; Bernoco D; Park MS; Cicciarelli J; Heintz R; Saxton RE; Burk MW; Morton DL
Cancer Res; 1982 Feb; 42(2):409-11. PubMed ID: 7055793
[TBL] [Abstract][Full Text] [Related]
28. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
[TBL] [Abstract][Full Text] [Related]
29. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
Ferrini S; Cantoni C; Ciccone E; Biassoni R; Prigione I; Bottino C; Venzano P; Moretta L
Eur J Immunol; 1991 Sep; 21(9):1981-7. PubMed ID: 1832383
[TBL] [Abstract][Full Text] [Related]
30. [A strategy for the production of human monoclonal antibodies].
Chiba J
Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
[TBL] [Abstract][Full Text] [Related]
31. [Human monoclonal antibodies with human-mouse hybridomas].
Naoe T; Kato K; Shiku H; Yamada K
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2575-81. PubMed ID: 6606396
[TBL] [Abstract][Full Text] [Related]
32. In vitro immunization of human B lymphocytes with cultured melanoma cells (SK-MEL 28).
Zhang XM; Borrebaeck CA
Hum Antibodies Hybridomas; 1990; 1(1):42-6. PubMed ID: 1966473
[TBL] [Abstract][Full Text] [Related]
33. Antigen-based immunofluorescence analysis of B-cell targeting: advanced technology for the generation of novel monoclonal antibodies with high efficiency and selectivity.
Tomita M; Fukuda T; Ozu A; Kimura K; Tsong TY; Yoshimura T
Hybridoma (Larchmt); 2006 Oct; 25(5):283-92. PubMed ID: 17044784
[TBL] [Abstract][Full Text] [Related]
34. A unique human B lymphocyte antigen defined by a monoclonal antibody.
Meeker TC; Miller RA; Link MP; Bindl J; Warnke R; Levy R
Hybridoma; 1984; 3(4):305-20. PubMed ID: 6441771
[TBL] [Abstract][Full Text] [Related]
35. Improved fusion partners transfected with DNA fragment encoding IL-11 on generation of human B lymphocyte hybridomas.
Zhu Y; Jin B; Jiang S; Sun K; Sun C; Liu X
Hum Antibodies; 1999; 9(1):1-7. PubMed ID: 10331181
[TBL] [Abstract][Full Text] [Related]
36. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
38. Human-human hybridomas generated with lymphocytes from patients with colorectal cancer.
Borup-Christensen P; Erb K; Jensenius JC; Svehag SE; Nielsen B
Cancer Detect Prev Suppl; 1987; 1():207-15. PubMed ID: 3480051
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
Saxton RE; Mann BD; Morton DL; Burk MW
Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
[TBL] [Abstract][Full Text] [Related]
40. Production of human monoclonal antibodies to B lymphocyte cell surface antigens by in vitro immunization and human-human hybridoma technology.
Power DA; Gerkis V; d'Apice AJ
Hum Antibodies Hybridomas; 1990; 1(1):34-41. PubMed ID: 2103351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]